# Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

> **NCT04536675** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 204 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Vilanterol and Umeclidinium Bromide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04536675
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2023-11
- **Final completion:** 2024-04
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2021-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04536675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04536675, "Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04536675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*